Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Globus Medical, Inc.
Globus Medical, Inc. News
Globus Medical, Inc. Quantitative Score

About Globus Medical, Inc.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Globus Medical, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Globus Medical, Inc. Financials
Table Compare
Compare GMED metrics with: | |||
|---|---|---|---|
Earnings & Growth | GMED | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | GMED | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | GMED | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | GMED | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Globus Medical, Inc. Income
Globus Medical, Inc. Balance Sheet
Globus Medical, Inc. Cash Flow
Globus Medical, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Neutral |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Globus Medical, Inc. Executives
| Name | Role |
|---|---|
| Mr. Daniel T. Scavilla | President, Chief Executive Officer & Director |
| Mr. David C. Paul | Co-Founder & Executive Chairman |
| Mr. Keith W. Pfeil | Chief Financial Officer & Chief Operating Officer |
| Ms. Kelly G. Huller Esq. | Executive Vice President, General Counsel & Corporate Secretary |
| Mr. Brian J. Kearns | Senior Vice President of Business Development & Investor Relations |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Daniel T. Scavilla | President, Chief Executive Officer & Director | Male | 1965 | 1.92M |
| Mr. David C. Paul | Co-Founder & Executive Chairman | Male | 1967 | 1.49M |
| Mr. Keith W. Pfeil | Chief Financial Officer & Chief Operating Officer | Male | 1979 | 1.1M |
| Ms. Kelly G. Huller Esq. | Executive Vice President, General Counsel & Corporate Secretary | Female | 1972 | 789.51K |
| Mr. Brian J. Kearns | Senior Vice President of Business Development & Investor Relations | Male | 1967 | -- |
Globus Medical, Inc. Insider Trades
| Date | 15 Sep |
| Name | RHOADS ANN D |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 10000 |
| Date | 18 Jul |
| Name | Pfeil Keith W |
| Role | President, CEO |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 40000 |
| Date | 18 Jul |
| Name | Kline Kyle |
| Role | Senior Vice President, CFO |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 20909 |
| Date | 18 Jul |
| Name | Kline Kyle |
| Role | Senior Vice President, CFO |
| Transaction | Disposed |
| Type | |
| Shares | 5000 |
| Date | 18 Jul |
| Name | Kline Kyle |
| Role | Senior Vice President, CFO |
| Transaction | Disposed |
| Type | |
| Shares | 5000 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 15 Sep | RHOADS ANN D | Director | Disposed | S-Sale | 10000 |
| 18 Jul | Pfeil Keith W | President, CEO | Acquired | A-Award | 40000 |
| 18 Jul | Kline Kyle | Senior Vice President, CFO | Acquired | A-Award | 20909 |
| 18 Jul | Kline Kyle | Senior Vice President, CFO | Disposed | 5000 | |
| 18 Jul | Kline Kyle | Senior Vice President, CFO | Disposed | 5000 |